Insmed Incorporated
INSM
$72.65
$2.453.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -26.60% | -38.75% | -22.79% | 1.67% | -16.20% |
| Total Depreciation and Amortization | 0.14% | -1.53% | 6.13% | 17.20% | -6.13% |
| Total Amortization of Deferred Charges | -0.13% | -11.63% | -6.34% | 4.33% | 8.21% |
| Total Other Non-Cash Items | -85.19% | 22.18% | 11.75% | -22.14% | 83.85% |
| Change in Net Operating Assets | 266.65% | 34.37% | 1,915.56% | -165.81% | -73.39% |
| Cash from Operations | -49.81% | -32.70% | -0.13% | -25.79% | -26.83% |
| Capital Expenditure | -214.54% | -29.26% | -38.91% | -37.70% | 54.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3,401.77% | -10,096.82% | 100.00% | 566.67% | -84.18% |
| Cash from Investing | 7,207.71% | -14,140.45% | 97.53% | 609.87% | -91.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -158.83% | 39.74% | 33.57% | -94.06% | 409.17% |
| Issuance of Common Stock | -88.76% | 16,895.22% | 1,625.79% | 255.75% | -53.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 66.42% | 100.00% |
| Cash from Financing | 29.24% | 31,701.44% | 1,663.06% | 857.39% | -83.42% |
| Foreign Exchange rate Adjustments | -248.42% | -15.18% | 79.78% | -3,186.21% | 188.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,074.66% | -524.44% | 282.87% | 207.82% | -100.72% |